Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the "Farmacia popular" program in Brazil: an interrupted time series study.

ABSTRACT: BACKGROUND:Increasing medicines availability and affordability is a key goal of Brazilian health policies. "Farmácia Popular" (FP) Program is one of the government's key strategies to achieve this goal. Under FP, antihypertension (HTN) and antiglycemic (DM) medicines have been provided at subsidized prices in private retail settings since 2006, and free of charge since 2011. We aim to assess the impact of sequential changes in FP benefits on patient affordability and government expenditures for HTN and DM treatment under the FP, and examine their implications for public financing mechanisms and program sustainability. METHODS:Longitudinal, retrospective study using interrupted time series to analyze: HTN and DM treatment coverage; total and per capita expenditure; percentage paid by MoH; a

SUBMITTER: Emmerick ICM 

PROVIDER: S-EPMC6951004 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature